SomaLogic and Korea’s DNA Link partner to bring the 7,000-plex SomaScan® platform to the fast-growing Asia-Pacific proteomics market
DNA Link will bring the power of the largest proteomics platform available to their biomarker discovery and drug development work BOULDER, Colo. and SEOUL, Korea, Sept. 19, 2023 (GLOBE NEWSWIRE) — SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology,